商业制备纳米脂肪系统的第一次比较:技术性能和生物质量在获得的产品之间有所不同
Robin Arcani1,2, Maxime Abellan2,3, Stéphanie Simoncini2
1Internal Medicine and Therapeutics Department, CHU La Timone, AP-HM, Marseille, France.
Scientific reports
|February 20, 2026
概括
这项研究比较了八种纳米脂肪制备系统,发现设备选择显著影响生物质量和再生潜力. 为了在再生医学中获得一致的纳米脂肪结果,需要标准化的方法.
科学领域:
- 再生医学是一种再生医学.
- 生物技术是生物技术.
- 组织工程是组织工程.
背景情况:
- 纳米脂肪是一种脂肪移植技术,在再生医学中越来越多地使用.
- 目前的制备方法缺乏标准化,导致纳米脂肪质量变化.
- 缺乏商业纳米脂肪制备系统的全面比较.
研究的目的:
- 综合比较不同纳米脂肪制备系统的技术和生物性能.
- 评估来自各种设备的纳米脂肪的细胞活力,产量,免疫类型和克隆性能力.
- 评估纳米脂肪中的细胞外囊含量和组织结构保存.
主要方法:
- 八个商业纳米脂肪制备设备与来自五个捐赠者的脂酸盐一起使用.
- 评估了技术参数 (准备时间,产量,易度) 和生物分析 (细胞活力,产量,免疫类型,克隆性).
- 细胞外囊泡被量化,通过显微镜评估组织结构.
主要成果:
- 所有设备都显示出令人满意的技术性能;Puregraft Boost V2和Emulsfat在技术上获得了最高分.
- 在所有设备中,细胞活力都很高 (>85%).
- 阿迪尼泽产生了最多的脂肪衍生的树皮/干细胞,并且具有最高的生物分数,而Hy-Tissue Nanofat具有最低的细胞产量.
结论:
- 纳米脂肪的特性取决于设备,在技术易用性和生物质量之间存在潜在的权衡.
- 标准化的制备方法和资格标准对于优化再生结果至关重要.
- 这项研究为根据特定的临床目标选择纳米脂肪设备提供了指导.
更多相关视频
09:33Asymmetrical Flow Field-Flow Fractionation for Sizing of Gold Nanoparticles in Suspension
Published on: September 11, 2020
6.8K
07:54Capillary Electrophoresis Mass Spectrometry Approaches for Characterization of the Protein and Metabolite Corona Acquired by Nanomaterials
Published on: October 27, 2020
4.9K
相关概念视频
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:17Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:20Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...